🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a prospective Bayesian adaptive randomized phase II clinical ...
Status
Recruiting
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
Start Date
2025-01-01
Trial ID
NCT06936046
Treatments Being Tested
GC004 is a Phase I trial to evaluate the safety and the immune responses of...
Status
Unknown
Location
Multiple Locations
Start Date
2020-07
Trial ID
NCT04428073
Treatments Being Tested
The purpose of this study is to evaluate the safety and immunogenicity of t...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-12-19
Trial ID
NCT02298179
Treatments Being Tested
The research objective is to evaluate the safety and tolerability of the in...
Status
Unknown
Location
Hebei Provincial Center for Disease Control and Prevention
Start Date
2021-08-03
Trial ID
NCT06350058
Treatments Being Tested
This is a phase 1 study to assess the safety and immunogenicity of differen...
Status
Completed
Location
Josha Research
Start Date
2022-05-30
Trial ID
NCT05228314
While total hysterectomy without lymph node staging is standard for low- an...
Status
Completed
Location
1. Department of Gynecologic Oncology, Moscow City Oncology Hospital No. 62
Start Date
2021-07-01
Trial ID
NCT04972682
What is the research question being addressed? Does combining Turbinaria or...
Status
Enrolling By Invitation
Location
Allama Iqbal Medical college
Start Date
2026-08
Trial ID
NCT07786389
Treatments Being Tested
Primary objective: To compare the event rate of CDI in groups assigned to A...
Status
Completed
Location
Multiple Locations
Start Date
2009-02
Trial ID
NCT00772343
This study will evaluate the safety, tolerability, and immunogenicity of va...
Status
Completed
Location
Multiple Locations
Start Date
2013-11-25
Trial ID
NCT01986010
Cilengitide 2000 mg flat i.v. twice weekly is administered over a period of...
Status
Unknown
Location
Royal North Shore Hospital
Start Date
2009-11
Trial ID
NCT01124240
Treatments Being Tested